Dose escalation study of paclitaxel in combination with fixed-dose irinotecan in patients with advanced non-small cell lung cancer (JCOG 9807)YAMADA, Kouzo; IKEHARA, Mizuki; TANAKA, Gaku et al.Oncology. 2004, Vol 66, Num 2, pp 94-100, issn 0030-2414, 7 p.Article

Randomized study of dose or schedule modification of granulocyte colony-stimulating factor in platinum-based chemotherapy for elderly patients with lung cancerOSHITA, Fumihiro; YAMADA, Kouzo; NOMURA, Ikuo et al.Oncology reports. 2001, Vol 8, Num 4, pp 861-866, issn 1021-335XArticle

Detection of occult tumor cells in peripheral blood from patients with small cell lung cancer by promoter methylation and silencing of the retinoic acid receptor-βOSHITA, Fumihiro; SEKIYAMA, Akiko; SUZUKI, Rie et al.Oncology reports. 2003, Vol 10, Num 1, pp 105-108, issn 1021-335X, 4 p.Article

Expression of vascular endothelial growth factor and basic fibroblast growth factor in small adenocarcinomasITO, Hiroyuki; OSHITA, Fumihiro; NAKAYAMA, Haruhiko et al.Oncology reports. 2002, Vol 9, Num 1, pp 119-123, issn 1021-335XArticle

Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancerOSHITA, Fumihiro; YAMADA, Kouzo; KATO, Yuji et al.Cancer chemotherapy and pharmacology. 2003, Vol 52, Num 1, pp 73-78, issn 0344-5704, 6 p.Article

Increased expression levels of p53 correlate with good response to cisplatin-based chemotherapy in non-small cell lung cancerOSHITA, Fumihiro; NISHIO, Kazuto; ITO, Hiroyuki et al.Oncology reports. 2000, Vol 7, Num 6, pp 1225-1228, issn 1021-335XArticle

Genome-wide cDNA microarray screening to correlate gene expression profile with survival in patients with advanced lung cancerIKEHARA, Mizuki; OSHITA, Fumihiro; SEKIYAMA, Akiko et al.Oncology reports. 2004, Vol 11, Num 5, pp 1041-1044, issn 1021-335X, 4 p.Article